Since IKKβ has been identified as an Hsp90 client protein [19,20], we hypothesize that combined treatments with 17-DMAG and TNF may lead to a promising anti-tumor effects if 17-DMAG can decrease the survival signaling properties of TNF. This evidence concerns the gene TNF and neoplasm.